PhD position - Antisense oligionucelotide treatment for MAST1 associated epilepsy

Select the region that best fits your location or preferences.

This setting controls the language of the user interface, including buttons, menus, and all site text. Select your preferred language for the best browsing experience.

Select the languages for job listings you want to see. This setting determines which job advertisements will be displayed to you.

• Swedish
• Norsk
• Danish
• Finnish
• German
• French
• Dutch
• Spanish

Job Match Comparison

Compare your profile with the job requirements

Job or profile information is not available.

Why this job matches your profile

We\'ve compared your profile to the job requirements. Here\'s where they align.

Job or profile information is not available.

You have already applied for this position.For questions regarding your application, please contact the employer.For technical assistance, reach out to our support teamhere .

Thank you for your application! An email confirmation has been sent to your email.

Loading job alert...

Receive job alerts that match your preferences.

Select employers Search and select specific employers to receive job alerts only from them.

PhD position - Antisense oligionucelotide treatment for MAST1 associated epilepsy

Subject areas/Research fields: Cerebral Organoids, Brain Development, iPSCs.

Keywords: Neuroscience, Disease Modelling, Cell Biology

Nameof supervisor: Prof. Dr David Keays

Funding: LSM-CSC/ DAAD-GSSP (LSM)

Project title: Antisense oligionucelotide treatment for MAST1 associated epilepsy

Epilepsy is a severe chronic neurological disorder that affects more than 50 million people worldwide. Mutations in MAST1, an uncharacterised serine/threonine kinase, are known to cause epilepsy through a gain of function mechanism. In this project will exploit modified antisense oligonucleotides (ASOs) that target recurrent pathogenic mutations in MAST1. We will test the efficancy of this approach using a platform that relies on human stem cells, harbouring MAST1 mutations. Working closely with industry partners we will use these cells, to generate “min-brains” within the laboratory which model multiple aspects of brain development and have been shown to recapitulate epileptic phenotypes. The student will become skilled in 3D cell culture, physiological methods, single cell sequencing, and will be well positioned for a career that bridges academic and commercial science.

Apply: Please send your application through the online portal of the Graduate School Life Science Munich (LSM)

Job details

Title

PhD position - Antisense oligionucelotide treatment for MAST1 associated epilepsy

Ludwig-Maximilians-Universität München is a leading research university in Europe. Since its founding in 1472 it has been committed to the highest ...

#J-18808-Ljbffr